Çѱ¹ÀÇÇÐ³í¹® µ¥ÀÌÅͺ£À̽º
Á¦¸ñ ¼Ò¾Æ COVID-19 »ç·Ê ÀÓ»óÀû Ư¼º ¹× ¿ªÇÐ
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

 

¼Ò¾Æ COVID-19 »ç·Ê ÀÓ»óÀû Ư¼º ¹× ¿ªÇÐ

(¾Æµ¿ÀÇ Äڷγª19 Æò±ÕÀẹ±â, Äڷγª19 °¨¿°µÈ ¼Ò¾ÆȯÀÚ »ó±âµµ¿¡¼­ ¹ÙÀÌ·¯½º ¹èÃâ±â°£, ¼Ò¾ÆȯÀÚÀÇ ÀÓ»óÀû Ư¼º ¹× Ç×¹ÙÀÌ·¯½º Ä¡·áÁ¦)

Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis

 

Key points :  

  • ¾Æµ¿ÀÇ Äڷγª19 Æò±ÕÀẹ±â 
  • Äڷγª19 °¨¿°µÈ ¼Ò¾ÆȯÀÚ »ó±âµµ¿¡¼­ ¹ÙÀÌ·¯½º ¹èÃ⠱Ⱓ
  • ¼Ò¾ÆȯÀÚ ´ëº¯¿¡¼­ Äڷγª¹ÙÀÌ·¯½º(SARS-CoV-2) ¹èÃâ ¿©ºÎ
  • COVID-19¿¡ °¨¿°µÈ ¼Ò¾ÆȯÀÚÀÇ ÀÓ»óÀû Ư¼º 
  • °¡Àå ¸¹ÀÌ »ç¿ëµÈ Ç×¹ÙÀÌ·¯½º Ä¡·áÁ¦

 

 

COVID-19 °¨¿° ¾Æµ¿Àº ¹Ì±¹¿¡¼­ 1,821,746¸íÀÌ ¾ç¼º ÆÇÁ¤À» ¹Þ¾Ò´Ù(¹Ì±¹ÀÇ °ø°³µÈ µ¥ÀÌÅÍ, 12¿ù 17ÀÏÀÚ º¸°í) . ÀÌ´Â Àüü Äڷγª19 ¾ç¼º ÆÇÁ¤À» ¹ÞÀº »ç·ÊÀÇ 12.3%¸¦ Â÷ÁöÇÑ´Ù.  ¹Ì±¹³»¿¡¼­ Áö³­ ÇÑ ÁÖ¿¡ 182,000¸íÀÌ ³Ñ´Â ½Å±Ô COVID-19 ¾Æµ¿È¯ÀÚ°¡ ¹ß»ýÇßÀ¸¸ç, ÀÌ´Â ´ëÀ¯ÇàÀÌ ½ÃÀÛµÈ ÀÌÈÄ °¡Àå ³ôÀº Áõ°¡¸¦ ³ªÅ¸³»¾ú´Ù.  ÇöÀç COVID-19·Î ÀÎÇÑ ÁßÁõÀº ¾î¸°À̵鿡°Ô µå¹°°Ô º¸ÀδÙ. ±×·¯³ª ¹ÙÀÌ·¯½º°¡ °¨¿°µÈ ¾î¸°ÀÌÀÇ Àå±âÀûÀÎ ½Åü °Ç°­¿¡ ´ëÇÑ À¯Çؼº°ú Á¤¼­Àû ¹× Á¤½Å °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÏ¿© COVID-19 ÆÒµ¥¹ÍÀÌ ¾î¸°ÀÌ¿¡°Ô ¹ÌÄ¡´Â Àå±âÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ ´õ ¸¹Àº µ¥ÀÌÅ͸¦ ¼öÁýÇؾßÇÏ´Â ½Ã±ÞÇÑ Çʿ伺ÀÌ Á¦±âµÇ°í ÀÖ´Ù.



 

±×¸² 1.  United States: Number of Child COVID-19 Cases Added in Past Week

(Source: American Academy of Pediatrics)




 

¾Æµ¿ÀÇ Äڷγª19 Æò±ÕÀẹ±â, »ó±âµµ ¹ÙÀÌ·¯½º ¹èÃâ±â°£, ´ëº¯¼Ó ¹ÙÀÌ·¯½º

ÃÖ±Ù Äڷγª19 ¼Ò¾ÆȯÀÚ¸¦ ´ë»óÀ¸·Î ºÐ¼®ÇÑ Ã¼°èÀû °íÂû /¸ÞŸºÐ¼® ¿¬±¸°á°ú¿¡ µû¸£¸é, COVID-19 ¼Ò¾ÆȯÀÚÀÇ Æò±Õ Àẹ±â´Â 9.57ÀÏ (95 % CI 7.70-11.44)·Î ³ªÅ¸³µ´Ù.  »ó±âµµ¿¡¼­ SARS-CoV-2ÀÇ ¹èÃâÀº 11.43 ÀÏ µ¿¾È Áö¼ÓµÇ¾úÀ¸¸ç, ¼Ò¾ÆȯÀÚÀÇ 75%´Â ´ëº¯¿¡ COVID-19 ¹ÙÀÌ·¯½º°¡ ³ªÅ¸³µ´Ù.

 

¾Æµ¿ÀÇ COVID-19 °¨¿° ¿ªÇРƯ¼º

COVID-19 ¼Ò¾ÆȯÀÚÀÇ Æò±Õ ¿¬·ÉÀº 6.48¼¼ (95% CI 52.0-77.5)ÀÌ°í, 90%´Â °¡Á¤¿¡¼­ Á¢ÃË¿¡¼­ ¹ß»ýÇß´Ù. ÀÓ»ó ÁßÁõµµ ºÐ·ù´Â 66%°¡ °æÁõ¿¡¼­ Áߵ ÀÓ»óÁõÈıº(mild to moderate clinical syndromes)À» ³ªÅ¸³»¾ú´Ù. ¾à 23%ÀÇ ¾î¸°ÀÌ´Â ¹«Áõ»ó(asymptomatic)À̾úÀ¸¸ç, 27%´Â µ¿¹ÝÁúȯ, 29 %´Â ´Ù¸¥ °¨¿°ÀÌ ³ªÅ¸³µ´Ù. 

 

¾Æµ¿ÀÇ COVID-19 °¨¿° ÁÖ¿ä Áõ»ó ¹× Ç×¹ÙÀÌ·¯½º Ä¡·áÁ¦

COVID-19 ¼Ò¾ÆȯÀÚÀÇ ÁÖ¿ä Áõ»óÀº ¹ß¿­ (47%, 95 % CI 41-53%)°ú ±âħ (42%, 95% CI 36-48%)À¸·Î ³ªÅ¸³µ´Ù.  Àüü ¾î¸°ÀÌÀÇ 34 %°¡ ??È£Áß±¸°¨¼ÒÁõ(neutropenia)À» ¾Î°í ÀÖ¾ú°í,  26 %°¡ ¸²ÇÁ±¸Áõ°¡Áõ(lymphocytosis)ÀÌ ÀÖ¾ú´Ù. Åð¿øÀ² ¹× »ç¸Á·üÀº °¢ °¢ 79% ¹× 1% ¿´´Ù.  ¼Ò¾Æ COVID-19 ȯÀÚ¿¡¼­ °¡Àå ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â Ç×¹ÙÀÌ·¯½ºÁ¦´Â ÀÎÅÍÆä·Ð-¾ËÆÄ (81 %)·Î ³ªÅ¸³µ´Ù. 



 

º» ¿¬±¸´Â ¸ÞŸºÐ¼®À» ÅëÇÑ ÀÌ Ã¼°èÀûÀÎ °íÂûÀº SARS-CoV-2¿¡ °¨¿°µÈ ¾Æµ¿ÀÇ ¿ªÇÐ ½ºÆåÆ®·³°ú ÀÓ»óÀû Ư¼ºÀ» Æò°¡Çϱâ À§ÇØ ¼öÇàµÇ¾ú´Ù. °ü·Ã ÀÚ·á °Ë»öÀº ±¹Á¦ ¹× Áß±¹ °ø°³ µ¥ÀÌÅͺ£À̽º¸¦ ü°èÀûÀ¸·Î °Ë»öÇÏ¿© 2020³â 1 ¿ùºÎÅÍ 2020³â 5¿ù±îÁö ¸ðµç »ç·Ê ¿¬±¸¸¦ È®ÀÎÇß´Ù. ÀÌ Ã¼°èÀû °íÂû ¸ÞŸºÐ¼® ¿¬±¸´Â 96°Ç ³í¹® 7,004 »ç·Ê¸¦ ´ë»óÀ¸·Î ºÐ¼®µÇ¾ú´Ù.

 

°á·ÐÀûÀ¸·Î SARS-CoV-2 °¨¿° ¾Æµ¿¿¡ ´ëÇÑ °ø°³ µ¥ÀÌÅÍ´Â ¼ºÀο¡ ºñÇÏ¿© ¸Å¿ì Á¦ÇÑÀûÀÌ´Ù.  SARS-CoV-2 °¨¿° ¾Æµ¿¿¡ ´ëÇÑ »ó´ëÀûÀ¸·Î ³·Àº ºñÀ²°ú Á¦ÇÑµÈ °ø°³ µ¥ÀÌÅ͸¦ °¨¾ÈÇÒ ¶§ ÀÌ·¯ÇÑ °ÝÂ÷´Â ½Ã±ÞÇÏ°Ô ÇØ°áµÇ¾î¾ß ÇÑ´Ù.






 

      ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø




 

References

American Academy of Pediatrics. Children and COVID-19: State-Level Data Report. URL: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/



Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis. (2020). Front Pediatr. 2020 Nov 2;8:591132. doi: 10.3389/fped.2020.591132. 

 

 

 

 


2020-12-29 ¿ÀÈÄ 5:32:01, Á¶È¸¼ö : 2007